Abstract
The aim of this report is to provide details of the methodology and results of the Sri Lankan component of the Asia-Pacific Crohn's and Colitis Epidemiology Study. Fourteen state and private hospitals with specialist services in the Gampaha and Colombo districts were kept under surveillance over a 12 month period to recruit patients with newly diagnosed Inflammatory Bowel Disease (IBD) who were permanent residents of the Gampaha district. Thirty five cases (ulcerative colitis-21, Crohn's disease-13, IBD-undetermined-1) were detected, giving a crude annual IBD incidence of 1.59 per 100,000 population.
Highlights
A number of recent reports from the Asia-Pacific region indicate an increase in the incidence and prevalence of Inflammatory Bowel Disease (IBD) [1,2,3]
The district is served by 10 state sector hospitals; four offering specialist services (Colombo North Teaching Hospital, and Base Hospitals Negombo, Gampaha and Wathupitiwela) and six that do not
A survey among Medical Officers-in-Charge confirmed that state sector hospitals without specialist services in both Gampaha and Colombo districts neither treated nor followed-up IBD patients; suspected cases were referred for specialist care
Summary
A number of recent reports from the Asia-Pacific region indicate an increase in the incidence and prevalence of Inflammatory Bowel Disease (IBD) [1,2,3]. Robust epidemiological studies from the region are few, and most data are derived from hospital databases or hospital-based cross-sectional studies [3]. The recent AsiaPacific Crohn’s and Colitis Epidemiology Study (ACCESS) determined the incidence and phenotype of IBD in 8 countries across Asia, which included Sri Lanka, and in Australia [4]. This large scale population based study (involving a population of more than 30 million) reported a crude annual overall incidence of 1.37 per 100,000 population in Asia, and 23.67 per 100,000 in Australia. The incidence of IBD varied throughout Asia, but was still much lower than in Western populations (including Australia) [1].
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
